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Abstract
The interface of any given ligand and protein—normally considered a macro-
molecule—of a known or predicted/modeled structure can be computed by deter-
mining each potential ligand position, resulting in an array of possibilities which 
are finally expressed in numerical energy values based on their thermodynamic 
affinity. Over the past few decades, this premier approach technique has proved to 
be crucial as an automated method in drug design and discovery, as well as in other 
fields. Data are retrieved from contour surface calculations for each ligand probe 
and can be analyzed to delineate regions of attraction on the basis of energy levels. 
Negative energy levels from contours are used to infer protein-ligand affinity clefts 
and are therefore relevant to drug design. Accordingly, molecular docking, framed 
as the “new microscope,” is part of a group of in silico computational techniques 
that enable the behavior of molecular chemistry to be analyzed and predicted 
in an inexpensive manner. From the starting point of framing the key terms in 
the binomial macromolecule-ligand docking approach, this chapter presents an 
introductory description of the progress made in this field of research over the past 
several years, in addition to present and future perspectives. This chapter presents a 
broad plethora of possibilities arising from the old docking alternatives to the cur-
rent software technology and critically dissects and discusses the emerging trends. 
Despite the emergence of more degrees of freedom, a number of flexible conglom-
erates have not been well developed, and there are still computational limitations 
to solve, including several features in the focused technique. The present goals, 
such as molecular flexibility, binding entropy, and the presence of ions and solute 
conditions, are revisited with the purpose of anticipating the challenges, goals, and 
achievements in this field over the next few years or decades.
Keywords: molecules, modeling, structure, proteins
1. Introduction
In biology, dissimilar molecules dock and interact to enable the perpetuation of 
the primordial logistics of living organisms. Molecular docking methodologies can 
be used to identify the interaction between a small ligand and a target molecule and 
to determine whether they could behave in combination as the binding site of two or 
more constituent molecules with a given structure. The comparison of docking mol-
ecules for proteins, other drug-like molecules, or even fragments from the original 
molecule enables a pool of prominent candidates to be calculated with listed values. 
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Interestingly, a wide spectrum of molecular binding interactions can be explored 
with this technique, including lipid-protein, lipid-lipid, enzyme-substrate, drug-
enzyme, drug-nucleic acid, protein-nucleic acid, nucleic acid-nucleic acid, protein-
drug, and protein-protein potential affinities, with key functions in every molecular 
biological or biochemical stage, as well as structural coupling [1–2].
The analysis of the binding scores between the constituent molecules in molecu-
lar recognition is essential to explain the constitutive processes and subsequently 
suggest a possible therapy in the context of a particular disease. The molecular 
docking in silico approach seeks the optimization of this process, not only in terms 
of techniques but also in relation to time and economic resources. For instance, 
there is no microscope with a sufficient power of resolution to capture an image at 
the dynamic (real-time) molecular level, and accordingly, theoretical and com-
putational approaches can be used to predict the best binding and most probable 
trajectories. Faster techniques and reduced resources are related to efficiency, in 
contrast to in vitro approaches, in which the examination of every synthesized and 
purified protein can have higher time and material costs. On average, traditional 
in vitro research can take about a decade to complete and can cost around 800 
million USD; in silico method importantly diminishes these costs [3]. As such, due 
to the difficulties in determining the structures of complexes, in silico approaches, 
including molecular docking, are suitable for predicting binding modes by investi-
gating thousands of ligand positions using the lowest energy score analyzed.
Since 1975, the development of high-throughput protein purification X-ray 
crystallography and nuclear magnetic resonance spectroscopy has continued to 
advance, predominantly contributing to a better understanding of the structural 
details of macromolecules and complexes with ligands [4]. Molecular docking, as 
with many other in silico tools, has become more common and easier to apply to the 
field of drug discovery; however, it is not entirely dependent on molecular structure 
databases. It is not impossible to work with molecules that are absent from the data-
bases, as they can be modeled by using one or multiple similar structures to build a 
novel chimeric output that can mimic the original molecule. In the docking process, 
the parameters can be further adjusted to test the function of the drug molecule 
versus a particular target molecule.
After the molecular docking has been performed, the software executes a 
systematic search on the algorithm, in which the ligand conformation is recurrently 
approached until the minimum energy conformation is identified. The final result 
will have a negative value of ΔG (U total in kcal/mol), in which a number of electro-
static and van der Waals energy variables will have been synthesized. These energies 
are related through the interaction between two molecules. This association allows a 
final scoring function to classify the candidate positions through the driving forces 
of the specific interactions to be obtained. The structural shape and electrostatic 
forces of both the ligand and the target molecule at specific binding-site surfaces 
are key aspects in biological complementarity systems. In the drug discovery field, 
several key aspects must be considered when predicting whether the molecule 
will bind with the receptor target, such as the structural shape and electrostatic 
interactions of the protein-ligand, ligand-ligand, or protein-protein. In this sense, 
several physicochemical parameters, including the van der Waals forces, Coulombic 
interactions, and the formation of hydrogen bonds, play relevant roles. The com-
bination of all these values and potential binding is predicted by a docking score. 
Essentially, for drug design, it is possible to use a rigid system in which a rotational 
and translational space in six dimensions is explored to fit the ligand into a specific 
binding structure site [5].
The constantly growing number of biological targets for the design of rational 
structure-based ligands in public databases has gained interest in the research 
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community. In the drug discovery field, the essential processes in computational 
docking are the design of the ligand and the search for targets of the existing can-
didate ligands. The latter are used to predict a reliable binding affinity, in which the 
best possible physicochemical prediction of how the target and ligand will interact 
is made. A strategy to enhance the selection of drug candidate ligands is based on 
the scores obtained from in silico approaches. These scores not only significantly 
reduce the amount of inefficient compounds synthesized but also decrease the 
amount of unnecessary biological tests by taking into account valuable information 
about crucial binding elements in a given ligand-receptor conglomerate. Molecular 
docking approaches are used to calculate the scores of ligand-binding types and 
linking affinities. The estimation of reliable ligand-binding associations and modes 
is a difficult challenge. During the last few decades, the scientific community has 
gradually shown an increasing interest in molecular docking methods, illustrated 
by the increase in references and the number of publications in the field [6]. 
Nevertheless, there is currently no standard consensus regarding the criteria that 
should be used to classify a docking mode as correct or incorrect. Most docking 
methods are based on the use of general scoring functions to predict molecular 
suitability for a wide range of applications. In order to accomplish what is needed, a 
reliable scoring function, reasonable protein flexibility, and a treatment for ligand 
conformational changes are required.
In the context of molecular biology, the interactions between molecules are key 
to understanding the mechanisms that underlie a particular biomedical event. The 
latest achievements have been the improvement of computational methods essential 
to the process of drug discovery, modeling in the prelaminar stage, and the actual 
analysis of putative binding interactions. It is possible to conduct exploratory work 
by examining the best score function values or by using a large set of multivariate 
experimental data. In both cases, it is possible to analyze how changes in ligands or 
macromolecules can have an effect on their interactions by validating the associated 
biological processes, with the aim of gaining a better understanding of the interplay 
between the biomolecular functions of the bioactive candidates through the char-
acterization of the kinetics and binding score values imperative to their molecular 
recognition. In order to better understand the historical and conceptual implications 
of the development of this interesting and well-established technique, past and 
present achievements must be considered, as well as the current limitations with the 
potential to change the course of the technological methods developed in the future. 
In comparison to “wet lab” experimental procedures such as, e.g., microarray tech-
nology or even sequencing, virtual screening is inexpensive and efficient. However, 
several considerations need to be taken into account [7]. Overall, computational 
methods have been a recurrent option due to the focus approximation of the analysis.
2. The development of molecular docking techniques
As one of the most commonly used approaches since the 1980s, the experimen-
tal data obtained through molecular docking techniques have grown at an increas-
ing rate since the approach was first established. Programs configured through 
different algorithms for molecular docking analysis have been developed on an 
almost yearly basis, significantly improving pharmaceutical research [6]. The first 
algorithms were designed for protein-protein interactions. Along with the scoring 
function, which is used to determine the best binding poses, algorithms designed to 
calculate the best geometrically complementary shapes as rigid bodies are necessary 
to identify the most favorable orientations and conformational bindings with the 
potential to confer a putative drug candidate.
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The gradual achievement of more powerful and complex algorithms with the 
addition of further parameters has paralleled computational technological advances 
over the last few decades. In order to achieve optimum flexibility, in silico methods 
use different tools with different approaches. Docking software depends on the 
algorithms employed, which comprise three different kinds: systematic, stochastic, 
or deterministic.
In the beginning, calculation algorithms that consider docking complexes to 
be rigid structures were used. In rigid docking, the objective is to match the ligand 
to the protein receptor, with the main aim being the generation of as many poses 
as possible in order to achieve the optimum of all poses. Through this process, all 
possibilities are considered heuristically to identify a group of complementary 
matches that present the most favorable van der Waals forces between the ligand 
and the macromolecule receptor. Intermolecular interaction calculations avoid 
any flexibility but nevertheless have a level of freedom dependent on a 3x3 matrix 
plus the vector rotation. This means that three rotational and three translational 
degrees of freedom cover all possible moves in three-dimensional space within the 
active site. However, no binding is permitted, as the macromolecular structures are 
simplistically represented as solid structures located under a center of mass and 
longitude [8].
The earliest work was performed using structural shape contacts, in which the 
fitting of outlines enables the best possible complementary configuration between 
two proteins to be identified [9]. A little later, a shape matching strategy algorithm 
was used by Kuntz and collaborators in UCSF8 to continue searching for possible 
configurations using the geometric distance between the ligand atoms and the 
macromolecule or receptor spheres (Figure 1).
In this method, the ideal intersection or match between the ligand and recep-
tor is viewed as a “negative image” that represents the active site. The image is 
produced by covering the receptor surface region and overlapping spheres with a 
solvent, in which a part of the overlapping spheres comprises the actual binding 
site. This constitutes the fundamentals of the DOCK search algorithm [10]. A few 
years later, Kuntz also developed a more advanced approach by conferring flex-
ibility to the ligand; however, this variant is still categorized as “flexible docking.” 
Figure 1. 
Top left, binding site; top right, ligand. Down below conjugate with geometrical fitness functional group related 
proposed by the earliest docking algorithm model.
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Subsequently, the investigation of HIV-1 protease using this approach was notable 
for leading to the technique’s exponential use in drug discovery [11].
Following the pioneering work from Kuntz, a different approach was taken a 
decade later in order to develop an improved new geometric recognition method, 
which was developed through an algorithm called Fourier transformation [12]. For 
the first time, the molecules could be described by a digital model, allowing their 
interior and exterior parts to be distinguished. This novel method allows faster 
calculation by determining the surface of contact, overlap, and approximation 
using the six degrees of freedom. In this method, molecules are considered rigid 
bodies, and the changes in structure have the degrees of freedom. This technique 
makes it possible to process atomic coordinates, and Zdock represents an example 
of this approach. Nevertheless, rigid-body algorithms are very erratic and ineffec-
tive in terms of any structural and conformational change arising due to the inter-
face between the ligand and the receptor. In this context, new alternatives to enable 
torsions and angle movement became a matter of interest. In the same period, a new 
semiflexible docking innovation was achieved using the HADDOCK protocol [13], 
which involves rigid-body docking complemented by semiflexible optimization 
in order to describe possible torsion angles in the main backbone and side chains. 
Unlike the previous Fourier transformation method [12], which uses a grid, this 
method adopts a Cartesian approach with particular coordinates, in which one of 
the two molecules is flexible and the solvent can be selected. One of the two mole-
cules therefore needs to be small in order to be computationally possible in terms of 
the number of conformational variations. Other methods also attempt to describe 
flexible bodies undergoing rotational conformational, rotational, and translational 
changes, mimicking the nature of biological molecules. In this category, both the 
ligand and the receptor that are modeled by simulating protocols are flexible. 
However, the flexibility needs to be lowered to make computational configuration 
possible. In the end, flexible docking approaches offer a more precise technique 
capable of imitating in vivo behavior of the possible structural conformations.
In flexible docking, there are two different logarithmic approaches, determinis-
tic incremental construction and stochastic. Systematic incremental construction 
algorithms are most commonly used, which gradually develop binding predictions 
on the basis of all possible ligand-binding poses covering all specified areas, e.g., 
DOCK [14], Glide [15], LUDI [16] FlexX [17], Hammerhead [18], and Surflex 
[19], in which on-the-fly incremental ligand construction is implemented. In this 
method, the number of analyses grows in line with increases in the degrees of 
freedom as part of anchor-and-grow methods. In a different example, in eHiTS, the 
ligand is fragmented, and each piece is tested for rigid docking, commonly based 
on library screening for the best conformations to religate the fragments and test 
their flexibility.
A different approach randomizes probabilistic or stochastic algorithms to 
selectively reject or accept configurations through the criteria spectrum, in which 
computational efforts are optimized, e.g., AutoDock [20], DARWIN [21], Monte 
Carlo [22], and GOLD [23]. By the middle of the 1990s, this technique was the point 
of origin of a diverse set of methods that are most commonly present in the genetic 
algorithm, named after Darwin’s theory of evolution, in which the ligand is inter-
preted as a chromosome and its fragments are considered genes [24]. Every gene 
exhibits conformational behavior due to its torsional/translational nature. During 
computational analyses, the information is transmitted and altered through sto-
chastic crossover and mutational events evolving through specific parameters. The 
changes improve the conformational binding pose from the ligand and the receptor, 
e.g., Lamarckian (AutoDock). In the case of the Monte Carlo stochastic variant that 
produces randomized translational conformations, the most thermodynamically 
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stable potential bindings are explored by focusing on the local minimum energy 
using a decision criteria parameter that is based on a temperature reaction, called 
Metropolis. The flexibility also alternates with rigid rotation, displaying several 
parameters at once. A more recent development is the deterministic method, which 
has been used for Newton equation simulations and also employs Monte Carlo 
methods that can measure trajectories, using Amber, Charm, and GROMACS; 
however, this scope forms the focus of the present work, and wide reviews have 
been provided by other researchers [25–27].
3. Molecular docking at present: a diverse and common approach
The drug discovery informatics market had an estimated value of 713.4 million 
USD in 2016 [28]. The presence of in silico tools that can allow the computation 
of data flowing from diverse methodology pathways in parsimony with medical 
chemistry can be synergistic in terms of upgrading the market and are well-known 
in the scientific literature. In this manner, molecular docking has been consolidated 
as a useful technique among sequence analysis platforms, molecular modeling, and 
clinical training management. The use of molecular docking in each of these fields 
is enhancing drug discovery in the pharmaceutical and biotechnology sector. As 
it comprises several stages and workflows, the discovery of new drugs relies on in 
silico tools and molecular docking in particular to simplify the overall process.
A crucial factor is the steadily rising number of structures stored in the Protein 
Data Bank (PDB). The PDB is the most robust, currently storing over 151,000 
structures and counting. The 3D structure information bank includes a large set 
of proteins, lipids, carbohydrates, and nucleic acids, in both single structures and 
complexes [29]. On the other hand, nearly a hundred different forms of molecular 
docking software are available, which offer analogous implementations with vari-
ous implementation options. There has been rapid progress in developing faster 
architecture based on graphics processing unit clusters, more adequate algorithms 
for optimized computational analysis, and the tracking of ligand-receptor binding 
expressed in scoring functions.
Although there is a need to maintain computational equipment, the associated 
expenses are certainly lower than the costs of “wet lab” experiments, and molecular 
docking is therefore an affordable technique. One of the most challenging tasks 
in bioinformatics sciences is undoubtedly the development of new and effective 
drugs, which is currently an almost mandatory step before wet lab experiments. In 
structure-based drug modeling, obtaining the most accurate and efficient model of 
ligand-receptor binding is a crucial step and is a suitable starting point for further 
evaluation to test new compounds or drug candidates, but also and no less impor-
tantly, to discard the improbable candidates. Molecular-ligand docking is a signifi-
cant tool in pharmacology at present and an important area of drug discovery that 
has comprised a central node of important achievements over the current century. 
As an interdisciplinary process of multiple joint efforts mainly from the pharma-
ceutical sector, biotechnological companies, and academic researchers, as well as 
many other fields, the process is highly complex and requires the most accurate and 
precise tools and methodologies. This has been enhanced by an increasing number 
of protein coordinates and the high number of available software programs that are 
constantly evolving with more sophisticated levels and a wider field of applications, 
in combination with more numerous candidates. In order to discover new drugs, as 
well as improve the existing ones, it is necessary to understand the targets as well 
as the nature of the possible drug candidates. In silico bioinformatics approaches 
have attracted increased interest due to the results of post-genomic era sequencing. 
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Due to the limited set of protein-coding genes, the complexity is much higher due 
to posttranscriptional modifications, prosthetic groups, multimeric complexes, 
and other various phenomena, clearly demonstrating the need to better understand 
their nature to fulfill biomedical objectives. Interestingly this year’s (2019) publica-
tions account for the first time a pause in the upper trend of docking publication 
number (Figure 2). This may be symptomatic on how the future holds already 
crucial challenges.
4. Future challenges, endeavors, and perspectives
The drug discovery informatics market is estimated to grow from 1.5 billion 
in 2016 to 2.84 billion by 2022 and may continue expanding. Accordingly, there is 
currently a rising demand for the discovery and implementation of novel infor-
matics solutions. The major factors driving the expansion of the global market 
include the transition from pure research to clinical treatment. More skilled 
professionals, interdisciplinary backgrounds, and the high pricing of informatics 
software may have a crucial impact on the growing market. At present, a number of 
 well-established applications have been made available for free or as paid software 
or services. However, many challenges remain to be addressed to enable the full 
potential of this powerful technique to be realized.
Nevertheless, in the case of pharmacology, the synergistic aspect is an important 
chemical phenomenon in which two different biomolecules with different origins 
can have an exponential effect in combination that is greater than their separate 
effects. If it is determined that a particular structure is more favorable [30] in terms 
of the docking score and it may be correlated with synergism, this can be second-
ary, due to the fact that a molecular docking procedure has not been developed to 
examine it in a particular scoring function. A linear/quadratic formula could be 
developed to measure synergy by discriminating between synergistic, additive, or 
antagonistic effects, which can be expressed both qualitatively and quantitatively. 
In this sense, further work is needed to investigate how the chemosensitivity 
between a macromolecule and ligand could be detected once more than one ligand 
Figure 2. 
Chart bar displaying paper publications per year (1982–2020) (NCBI, accessed on January 12, 2019).
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is included. Although unmanageable amounts of data make this process difficult, 
it is possible to analyze the small targets that are the most restricted to the binding 
site being examined, especially in drug-protein analysis. System biology models that 
depend on a drug synergy test need to be developed in a more comprehensive man-
ner, perhaps by including qualitative features in combination with the quantitative. 
In this sense, a novel input could be developed in computational docking analysis to 
enable, e.g., the measurement of molecular signaling that has been established to be 
part of several components, ligands, or targets. These systematic synergy model-
ing methods could support drug synergy research with the aim of improving the 
accuracy of experimental results.
An improvement of the molecular structure databases is necessary for further 
development. Filters are needed to ensure the structural models they contain are 
of a better quality, as this will influence the reliability of the results. The PDB 
was established in 1971 as a pioneer crystal structure database, and today it is 
the most common source for molecular in silico modeling, harboring more than 
150,000 experimentally proven 3D models. However, there is no guarantee that the 
chosen structures are error-free, including even those with excellent geometrical 
parameters, and this must be taken into account. High-quality statistics are not an 
indication that the structure is perfect. Therefore, an improvement of their quality, 
protocols, and validation would allow the construction of better models that could 
be valuable in the inevitable task of structure refinement. However, a better model 
will not be more informative in terms of more detailed biological information, 
which means that the interpretation of a scientist will be necessary. However, the 
confirmation of outcomes and the precision of the docking tool in a certain interac-
tion can be tested. Although docking strategies have become more complex, false 
positives are a recurrent issue with this technique, and as such, refining the struc-
tures stored in the PDB will undoubtedly lead to an improvement and better results 
from pharmacodynamics studies [31].
Those who devote their time to molecular docking are well aware of the large 
number of docking techniques. In the years to come, docking experiments will need 
to be more consistent in terms of the outputs generated by different docking meth-
ods. Using meta-experimental databases, including a large-scale and diverse variety 
of targets and ligands, comparisons of scoring functions have shown that accuracy 
and reportability are far from being reached. A standardized common workflow 
that follows the same procedures and is associated with the same advantages and 
issues is therefore necessary. A streamlined validation process to define standard 
test protocols needs to be agreed for every aspect of the docking method; otherwise 
there will be a lack of reproducibility in the output process used by each research 
group and for each given software [32].
The interaction model of the ligand and the active site must achieve the most 
optimum site of recognition. Docking ensembles using rigid proteins can be 
slightly inaccurate. Through the ensemble, the protein can fluctuate according to 
the relative energy, with more time spent in the lowered energy structure. On the 
other hand, the conformations of ligands fluctuate partially, making the whole 
ensemble more stable. This can be misleading for dockings that are not flexible, 
due to the fact that a given conformation may not be the most stable choice in the 
structure. Up-to-date docking scores have been oriented for machine learning 
scoring and mainly consist of four building blocks: descriptors, a model, a training 
set, and a test set. Currently, SFCscore, NNscore, or RFscore represents promi-
nent examples of nonlinear and nontrivial correlations of data in order to avoid 
obstacles to interpretation [33]. Techniques that provide free access to the scoring 
function are still a minority and more options are needed, particularly those with 
open access. The number of poses needs to be exhaustive; however, this has not 
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been well-established. In this sense, we can state that the sensitivity of the original 
conformation of the ligands remains unanswered. Furthermore, in the case of mul-
tidomain proteins, proteins are frequently composed of more than a single effector 
domain, and this should be taken into consideration.
With regard to a different aspect, how water is placed around the binding site 
is not a straightforward problem to solve, although recent studies have proposed 
the use of this parameter as functionally valid in specific contexts [34] within and 
around the conglomerate binding site. X-ray crystallography is the most extensively 
used tool for predicting 3D conformational structure; however, the actual output is 
only partially informative, due to the fact that the density limits are out of resolu-
tion and, on occasion, the electron density can be of insufficient quality. Future 
efforts need to endorse novel alternatives to increase the capacity and parameters 
that can be used in every aspect of a given analysis, not only in terms of water but 
also the physiological solutes found in nature and even protonation, in addition to 
the pH potency spectra.
An understanding of the biological functions and roles of a protein in a particu-
lar cell or tissue is highly relevant in determining the role of a protein’s structure, 
including all of its functional domains. Genome-wide studies have demonstrated 
that multidomains are present in over 70% of eukaryotic proteins. Nevertheless, 
protein-folding studies usually consider only single domains and are therefore not 
focused on the mechanisms in multidomains that can even influence the folding 
structure [34]. Very crucial obstacles are involved in multidomain docking analyses. 
In some examples, the understanding of intermolecular movement can be restricted 
by rigid docking methodologies that lack the ability to consider the effect of mul-
tiple domains in a single macromolecule. A given protein is not always present in a 
static and simplistic single conformational shape but can be present in a collection 
of scaffolds, stages, and intersections of conformational shapes. As a consequence, 
the free energy landscape can be profoundly affected, distinctively changing the 
scoring function’s output. This continues to present a major issue [35].
To improve modeling, the role played by multiple molecules in the context of 
a certain reaction is an indispensable step that must be considered. At the current 
stage of technology, this does not fall under the current scope of molecular docking, 
due to the fact that the processes are far too complex and it is difficult to manage 
all of the interactions that occur during a molecular binding and reaction. In order 
to mimic how chemistry works in nature, the inclusion of more than two factors 
(ligand/macromolecule) where methodologically possible would be a priority to 
enable the possible interactions in a molecular group to be predicted. Although a 
few software packages use this approach, in the future, it needs to become more 
common in other methods to address the binding modes of ligands in assessments 
with higher stoichiometry using multiple ligand complexes against the molecular 
target. Additionally, as stated earlier in this work, it would be of great interest to 
evaluate the synergy of ligand combination conjugates.
5. Conclusion
Over the last four decades, molecular docking has improved quite remarkably, 
contributing to the enhancement and improvement of pharmacology in addition 
to many different areas of applied and molecular biology. After the first complete 
draft of the Human Genome Project was announced in 2003, the scientific com-
munity concluded that there are far fewer protein-coding genes than expected and 
it has therefore been swift to study how molecules interact by investigating more 
possible target bindings of a given molecule. The increasing demand for molecular 
Drug Discovery and Development - New Advances
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docking has paralleled the revolutionary advancement of its technological back-
ground. Nevertheless, several biochemical and physical properties of proteins, 
particularly at the surface of contact, need to be included in docking algorithms in 
conjunction with those already present. On the other hand, the question of how 
to diminish unnecessary calculations and outputs from undesirable rotations and 
therefore translations is a big challenge to be considered in the near future, espe-
cially in virtual screening. The right implementation needs to be standardized, and 
closer multi- and interdisciplinary teams must overcome this challenge in order to 
fine-tune this already widely explored technique.
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